86.22.Z - Specialist medical practice activities
47.99.Z - Other retail sale not in stores, stalls or markets
62.01.Z - Computer programming activities
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.21.Z - General medical practice activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -0,6 | -0,6 | -0,6 | 0 |
EBITDA | -0,6 | -0,6 | -0,6 | 0 |
Short time liabilities | 7 | 7,6 | 8,3 | 8 |
Equity capital | -5,5 | -6,1 | -6,7 | -10,1 |
Operating profit (EBIT) | -0,6 | -0,6 | -0,6 | 0 |
Assets | 1,6 | 1,6 | 1,6 | 0 |
Net profit (loss) | -0,6 | -0,6 | -0,6 | 0 |
Cash | 1,6 | 1,6 | 1,6 | 0 |
Liabilities and provisions for liabilities | 7 | 7,6 | 8,3 | 8 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 1,6 | 1,6 | 1,6 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 11,3 | 10,1 | 9,2 | -0,9 |
Equity capital to total assets | -349 | -388,3 | -427,6 | -39,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.22269882261753082 | 0.20478151738643646 | 0.18953262269496918 | 0 |
Net dept to EBITDA | -3.958780288696289 | -3.958780288696289 | -3.958780288696289 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane